North America
The market for Furosemide Prices in the North American region fluctuated in the fourth quarter of 2022. Prices started to rise in Q4 2022 and kept growing due to high manufacturing costs, numerous logistical problems, and rising inflation through the second month of the fourth quarter. Growing transportation costs and port congestion at the key ports also helped to maintain the market position. Furthermore, a slowdown in API output due to rising energy prices had a favorable positive effect on the market situation. Later in December, prices started to drop as a result of weakening inflation and declining end-user sector demand as the festival season drew near. The settlement price for Furosemide API dropped to USD 80425/MT CFR in Los Angeles in December.

Asia
The fourth quarter of 2022 saw a tumultuous trajectory for the Asia Pacific Furosemide API market. It was stated at the beginning of Q4 2022 that rising end-user sector demand, a number of logistical difficulties, and rising inflation would cause prices to increase during the second month of the quarter. Due to rising production costs driven by rising energy prices and increased domestic production to fill demands from domestic and international markets, the market remained competitive. The strict zero covid regulations and frequent lockdowns in the Chinese regions have had an effect on the market. However, because domestic stores had enough supplies on hand later in December, Furosemide API prices did start to fall. However, because domestic retailers had enough supplies on hand later in December, furosemide prices did start to fall. The softening of the policies and the underwhelming downstream demand also contributed to the market's continued downturn. The settlement price for Furosemide API dropped to USD 75325/MT FOB Shanghai in December.

Europe
Prices of Furosemide API in the European region fluctuated in the fourth quarter of 2022. The demand for Furosemide API in the pharmaceutical industry's downstream market was seen to be stable. In the first two months of Q4 022, price increases were caused by the European region's continuous port congestion and supply disruption. Increased freight costs also had an impact on the trajectory of the API for furosemide. Because of the impending Christmas season and the need to prepare for it, European retailers have decided to restock their inventory significantly. However, due to a decline in inflation, relief from port congestion, and a little increase in domestic merchant stocks, prices fell significantly in the month of December. The cost of Furosemide API was USD 82515/MT CFR Hamburg toward the end of Q4 2022.

ChemAnalyst addresses the key problematic areas and risks associated with chemical and petrochemical business globally and enables the decision-maker to make smart choices. It identifies and analyses factors such as geopolitical risks, environmental risks, raw material availability, supply chain functionality, disruption in technology and so on. It targets market volatility and ensures clients navigate through challenges and pitfalls in an efficient and agile manner. Timeliness and accuracy of data has been the core competency of ChemAnalyst, benefitting domestic as well as global industry in tuning in to the real-time data points to execute multi-billion-dollar projects globally.